48 /100
MEDIUM RISK
Score updated Jul 13, 2026

DNA — Ginkgo Bioworks Holdings, Inc. Dilution Risk Tracker

Track DNA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DNA — Get alerts when the score changes →

As of July 13, 2026, Ginkgo Bioworks Holdings, Inc. (DNA) has a DilutionWatch DilutionScore of 48/100, rated MEDIUM dilution risk. Ginkgo Bioworks Holdings, Inc. has a market capitalization of $612.09M, 61.66M shares outstanding, 176 institutional holders tracked. Key dilution vectors include approximately 17 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for DNA.
🔔 Track DNA — Get forecast alerts →

💹 Market Data

Market Cap$612.09M
Shares Outstanding61.66M
Float47.85M
Cash$399.28M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 6.4% shares (2026Q1 vs prior)
176 institutional holders · 37.10M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 3.83M shares
#2 BlackRock, Inc. 3.64M shares
#3 VIKING GLOBAL INVESTORS LP 3.58M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest5.16M
Days to Cover4.0
% of Float10.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2025
4 INSIDER TRANSACTION Mar 18, 2026
4 INSIDER TRANSACTION Jan 22, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for DNA Shareholders

Ginkgo Bioworks Holdings, Inc. (DNA) has a DilutionScore of 48/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

Cash runway is a key watch item: DNA has approximately 17 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for DNA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for DNA alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track DNA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DNA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for DNA
📊 DNA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 DNA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.